Notably, bone samples from patients with CKD showed a trend toward increased SLC5A2 levels, although this was not statistically significant, this might suggest a potential disease-related regulatory mechanism.
← all excerpts
Bone from Healthy Individuals and Patients with CKD Expresses the Sodium-Glucose Co-transporter-2 (SGLT2).
1
—
—